Gilde Healthcare Holding B.V.'s Form 4 filing
LAVA Therapeutics NV (LVTX) · filed Oct 10, 2025
- Accession no.
- 0001193125-25-237275
- Filed
- Oct 10, 2025, 6:45 PM ET
- Trade date
- Oct 8-10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $197.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gilde Healthcare Holding B.V.CIK 0001420106 | 10% Owner |
| Cooperatieve Gilde Healthcare IV U.A.CIK 0001756335 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | Common Shares | SSaleDisposed | −28,954 | $1.57F1 | −$45,457.78 | 5,392,216 | Direct | |
| Oct 9, 2025 | Common Shares | SSaleDisposed | −48,169 | $1.56F3 | −$75,143.64 | 5,344,047 | Direct | |
| Oct 10, 2025 | Common Shares | SSaleDisposed | −49,869 | $1.55F4 | −$77,296.95 | 5,294,178 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This figure is the weighted average sales price of multiple trades ranging from $1.56 to $1.62 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
Referenced by the price of 1 transaction in Table I.
- F3
This figure is the weighted average sales price of multiple trades ranging from $1.54 to $1.59 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
Referenced by the price of 1 transaction in Table I.
- F4
This figure is the weighted average sales price of multiple trades ranging from $1.53 to $1.58 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
Referenced by the price of 1 transaction in Table I.